FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2561650646> ?p ?o ?g. }

• W2561650646 endingPage "311" @default.
• W2561650646 startingPage "300" @default.
• W2561650646 abstract "Abstract Neuropathic pain is a limiting factor of platinum-based chemotherapies. We sought to investigate the neuroprotective potential of niclosamide in peripheral neuropathies induced by oxaliplatin. Normal neuron-like and cancer cells were treated in vitro with oxaliplatin associated or not with an inhibitor of STAT3 and NF-κB, niclosamide. Cell production of reactive oxygen species and viability were measured by 2′,7′-dichlorodihydrofluorescein diacetate and crystal violet. Peripheral neuropathies were induced in mice by oxaliplatin with or without niclosamide. Neurologic functions were assessed by behavioral and electrophysiologic tests, intraepidermal innervation, and myelination by immunohistochemical, histologic, and morphologic studies using confocal microscopy. Efficacy on tumor growth was assessed in mice grafted with CT26 colon cancer cells. In neuron-like cells, niclosamide downregulated the production of oxaliplatin-mediated H2O2, thereby preventing cell death. In colon cancer cells, niclosamide enhanced oxaliplatin-mediated cell death through increased H2O2 production. These observations were explained by inherent lower basal levels of GSH in cancer cells compared with normal and neuron-like cells. In neuropathic mice, niclosamide prevented tactile hypoesthesia and thermal hyperalgesia and abrogated membrane hyperexcitability. The teniacide also prevented intraepidermal nerve fiber density reduction and demyelination in oxaliplatin mice in this mixed form of peripheral neuropathy. Niclosamide prevents oxaliplatin-induced increased levels of IL6, TNFα, and advanced oxidized protein products. Niclosamide displayed antitumor effects while not abrogating oxaliplatin efficacy. These results indicate that niclosamide exerts its neuroprotection both in vitro and in vivo by limiting oxaliplatin-induced oxidative stress and neuroinflammation. These findings identify niclosamide as a promising therapeutic adjunct to oxaliplatin chemotherapy. Mol Cancer Ther; 16(2); 300–11. ©2016 AACR." @default.
• W2561650646 created "2017-01-06" @default.
• W2561650646 creator A5013171964 @default.
• W2561650646 creator A5016913996 @default.
• W2561650646 creator A5017386958 @default.
• W2561650646 creator A5034892075 @default.
• W2561650646 creator A5036310972 @default.
• W2561650646 creator A5038293102 @default.
• W2561650646 creator A5041347383 @default.
• W2561650646 creator A5056283668 @default.
• W2561650646 creator A5056539042 @default.
• W2561650646 creator A5059590167 @default.
• W2561650646 creator A5060607593 @default.
• W2561650646 creator A5060959649 @default.
• W2561650646 creator A5061098159 @default.
• W2561650646 creator A5068650855 @default.
• W2561650646 creator A5090375155 @default.
• W2561650646 date "2017-02-01" @default.
• W2561650646 modified "2023-10-15" @default.
• W2561650646 title "Niclosamide Inhibits Oxaliplatin Neurotoxicity while Improving Colorectal Cancer Therapeutic Response" @default.
• W2561650646 cites W1847588449 @default.
• W2561650646 cites W1963663378 @default.
• W2561650646 cites W1965634002 @default.
• W2561650646 cites W1966456328 @default.
• W2561650646 cites W1966667955 @default.
• W2561650646 cites W1969851799 @default.
• W2561650646 cites W1972779889 @default.
• W2561650646 cites W1975134593 @default.
• W2561650646 cites W1978123764 @default.
• W2561650646 cites W1978803477 @default.
• W2561650646 cites W1979794557 @default.
• W2561650646 cites W1980562969 @default.
• W2561650646 cites W1981810830 @default.
• W2561650646 cites W1985042590 @default.
• W2561650646 cites W1998507857 @default.
• W2561650646 cites W2000401049 @default.
• W2561650646 cites W2006613730 @default.
• W2561650646 cites W2010720331 @default.
• W2561650646 cites W2011665876 @default.
• W2561650646 cites W2019413106 @default.
• W2561650646 cites W2022836457 @default.
• W2561650646 cites W2025968906 @default.
• W2561650646 cites W2031303958 @default.
• W2561650646 cites W2031389361 @default.
• W2561650646 cites W2065432788 @default.
• W2561650646 cites W2067500495 @default.
• W2561650646 cites W2067898251 @default.
• W2561650646 cites W2071620144 @default.
• W2561650646 cites W2071671774 @default.
• W2561650646 cites W2078500674 @default.
• W2561650646 cites W2082690420 @default.
• W2561650646 cites W2084255719 @default.
• W2561650646 cites W2084268808 @default.
• W2561650646 cites W2088667782 @default.
• W2561650646 cites W2089729192 @default.
• W2561650646 cites W2096610541 @default.
• W2561650646 cites W2098876426 @default.
• W2561650646 cites W2101371013 @default.
• W2561650646 cites W2104476156 @default.
• W2561650646 cites W2111964682 @default.
• W2561650646 cites W2123522220 @default.
• W2561650646 cites W2128073825 @default.
• W2561650646 cites W2128202887 @default.
• W2561650646 cites W2133944806 @default.
• W2561650646 cites W2137056778 @default.
• W2561650646 cites W2139058687 @default.
• W2561650646 cites W2139635582 @default.
• W2561650646 cites W2139955764 @default.
• W2561650646 cites W2149068355 @default.
• W2561650646 cites W2150759929 @default.
• W2561650646 cites W2152706544 @default.
• W2561650646 cites W2160855995 @default.
• W2561650646 cites W2161339168 @default.
• W2561650646 doi "https://doi.org/10.1158/1535-7163.mct-16-0326" @default.
• W2561650646 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27980107" @default.
• W2561650646 hasPublicationYear "2017" @default.
• W2561650646 type Work @default.
• W2561650646 sameAs 2561650646 @default.
• W2561650646 citedByCount "33" @default.
• W2561650646 countsByYear W25616506462017 @default.
• W2561650646 countsByYear W25616506462018 @default.
• W2561650646 countsByYear W25616506462019 @default.
• W2561650646 countsByYear W25616506462020 @default.
• W2561650646 countsByYear W25616506462021 @default.
• W2561650646 countsByYear W25616506462022 @default.
• W2561650646 countsByYear W25616506462023 @default.
• W2561650646 crossrefType "journal-article" @default.
• W2561650646 hasAuthorship W2561650646A5013171964 @default.
• W2561650646 hasAuthorship W2561650646A5016913996 @default.
• W2561650646 hasAuthorship W2561650646A5017386958 @default.
• W2561650646 hasAuthorship W2561650646A5034892075 @default.
• W2561650646 hasAuthorship W2561650646A5036310972 @default.
• W2561650646 hasAuthorship W2561650646A5038293102 @default.
• W2561650646 hasAuthorship W2561650646A5041347383 @default.
• W2561650646 hasAuthorship W2561650646A5056283668 @default.
• W2561650646 hasAuthorship W2561650646A5056539042 @default.
• W2561650646 hasAuthorship W2561650646A5059590167 @default.
• W2561650646 hasAuthorship W2561650646A5060607593 @default.

• next